Compare DexCom, Inc. (DXCM) vs D Wave Quantum Inc (QBTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs D Wave Quantum Inc — how do they compare? DexCom, Inc. trades at $77.84 (market cap $28.06B), while D Wave Quantum Inc trades at $17.53 (market cap $6.77B). The key difference: DexCom, Inc. is far larger — about 4.1× D Wave Quantum Inc's market cap, and DexCom, Inc. is trading nearer its 52-week high, D Wave Quantum Inc nearer its low. Which is the better fit depends on your goals.
| DXCM | QBTS | |
|---|---|---|
Market Cap | $28.06B | $6.77B |
Sector | Health | Technology |
52-Week High | $89.53 | $44.78 |
52-Week Low | $54.84 | $12.98 |
Enterprise Value | $27.03B | $6.23B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →
